Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 50 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Lambrinoudaki, Irene [Clear All Filters]
The Impact of Obesity on the Association between Vitamin D Deficiency and Cardiovascular Disease..
Nutrients. 11(10),
(2019). The interplay between diabetes mellitus and menopause: clinical implications..
Nat Rev Endocrinol.
(2022). Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options..
Int J Clin Pract. 70(12), 967-977.
(2016). Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement..
Maturitas. 131, 91-101.
(2020). Management of dyslipidaemias in the elderly population-A narrative review..
Maturitas. 124, 93-99.
(2019).
(2020). Maternal serum osteocalcin at 11-14 weeks of gestation in gestational diabetes mellitus..
Eur J Clin Invest. 45(10), 1025-31.
(2015). MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview..
Eur J Endocrinol. 176(6), R283-R308.
(2017). The Mediterranean diet and menopausal health: An EMAS position statement..
Maturitas. 139, 90-97.
(2020). Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?.
Curr Vasc Pharmacol. 17(6), 564-572.
(2019). Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization..
Maturitas. 81(4), 421-2.
(2015). Menopausal hormone therapy for women with obesity in the era of COVID-19..
Case Rep Womens Health. 27, e00233.
(2020). Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease..
Hormones (Athens).
(2022). Menopause in women with multiple sclerosis: A systematic review..
Maturitas. 135, 68-73.
(2020). Menopause symptom management in women with dyslipidemias: An EMAS clinical guide..
Maturitas. 135, 82-88.
(2020). Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society..
Maturitas. 163, 1-14.
(2022). Menopause-associated risk of cardiovascular disease..
Endocr Connect. 11(4),
(2022).
(2019). Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions..
Maturitas. 82(4), 444-5.
(2015). Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations..
Endocrine. 74(3), 478-497.
(2021). Sarcopenia in post-menopausal women: Is there any role for vitamin D?.
Maturitas. 82(1), 56-64.
(2015). Therapeutic strategies for type 2 diabetes mellitus in women after menopause..
Maturitas. 126, 69-72.
(2019). Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide..
Maturitas. 148, 55-61.
(2021). Updates on the treatment of invasive breast cancer: Quo Vadimus?.
Maturitas. 145, 64-72.
(2021). On the use and abuse of register studies: The case of menopausal hormone therapy..
Maturitas. 123, 91-92.
(2019).